BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
Metabolism of xenobiotics
,
Lung cancer
,
Breast
,
Biofuel
,
Lipitor
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
axitinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
ELN
COL1A2
MATN2
NUPR1
CX3CL1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FISCHER_DREAM_TARGETS
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
DODD_NASOPHARYNGEAL_CARCINOMA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
HUVECs treated with doxorubicin (topoisomerase-2 inhibitor) or with axitinib (VEGFRs inhibitor)
Explore Curated Studies Results
Literature
Most Relevant Literature
PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy.
Bilateral Central Retinal Vein Occlusion Associated with Axitinib Therapy: A Case Report.
Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable …
Plain language summary looking at how long side effects last after treatment with axitinib is stoppe…
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib
Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma
Prior Axitinib as a Determinant of Outcome of Renal Surgery
Avelumab, Palbociclib and Axitinib in Advanced RCC
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ